You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 8, 2026

In Vitro Directed Evolution of a Restriction Endonuclease with More Stringent Specificity
Published on: March 25, 2020
Anna R Batt1, Commodore P St Germain1, Trevor Gokey1
1Department of Chemistry & Biochemistry, San Francisco State University, San Francisco, California, 94132.
Developing protease therapeutics requires overcoming natural inhibitors. Key residues like Y39 and K60 in trypsin-fold proteases significantly influence inhibitor binding, guiding future drug design.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: